Scynexis inc.

Major-Pharmaceuticals

SCYX


101 Hudson Street
Jersey City , NJ 07302

Executive/
Director

Price

  • Last Close
  • $ 1.23
    $ -0.23 -15.52 %
    Dec 9, 2024
  • 52-Week High/Low
  • $3.64 - $1.39
  • YTD
  • -45.1%

  • Trading Volume
  • 2,511
  • Market Cap Full
  • $ 45.8M
  • Shares Outstanding
  • 37.2M
    Nov 1, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 -16.8% -35.1% -13.5% -42.2% 214.6% -5% 5.6% -37.1% 92.3% -34.1%
Q2 5.9% -46.2% -35.1% 24.2% -12.8% 4% -7.3% -52.4% -1.7% -2.7%
Q3 -17.2% 78.3% 34.6% -29% -13.4% 8% -28% 29% -22.7% -
Q4 -14.7% -17.6% -5.7% -60.7% -20.9% 70.5% 17.4% -35% 2.3% -
J F M A M J J A S O N D
2024 -7.6% -21.4% -9.3% -1.4% - - - - - - - -
2023 17.6% -18.8% 101.3% 5% -20.6% 18% - 19.3% -35.2% -17.1% -11.1% 32.7%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%-38%-49%-27%-79%81%764%-17%-75%43%-45%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.75 0.52 0.21 -0.12 -0.46 -0.7 -0.23 -0.18 -0.71
Q2 0.53 0.56 0.16 -0.23 -0.16 -0.64 -0.22 -0.31 2.46
Q3 0.54 0.35 0.27 0.01 -0.15 -0.28 -0.06 -0.62 -0.04
Q4 - - 0.27 0.06 -1.97 -3.51 -0.74 -0.36 -
A 1.8 1.4 0.9 -0.3 -2.7 -5.1 -1.3 -1.5 1.71

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 50.1 97.4 20.6 28.9 33.3
Jun 46.8 53.7 98.6 20.6 32.6 36.5
Sep 47 55.7 10.6 23.2 32.7 37.2
Dec 48 58.4 10.9 24 32.7 37.2

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 1 - - - -
Fixed Asset Turnover 0.8 2.2 - - -
Total Asset Turnover 0.1 0.1 - - -
Leverage
Debt Ratio 0.4 0.3 - - 0.3
Debt – Equity Ratio 11.3 0.7 - - 0.5
Interest Coverage 3.7 2.2 -12.8 -9.8 1.7
Equity multiplier 2 0.2 - 0.1 0.1